410 related articles for article (PubMed ID: 25594801)
1. Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome.
Camilleri M; Acosta A; Busciglio I; Boldingh A; Dyer RB; Zinsmeister AR; Lueke A; Gray A; Donato LJ
Aliment Pharmacol Ther; 2015 Mar; 41(5):438-48. PubMed ID: 25594801
[TBL] [Abstract][Full Text] [Related]
2. Effects of Colesevelam on Bowel Symptoms, Biomarkers, and Colonic Mucosal Gene Expression in Patients With Bile Acid Diarrhea in a Randomized Trial.
Vijayvargiya P; Camilleri M; Carlson P; Nair A; Nord SL; Ryks M; Rhoten D; Burton D; Busciglio I; Lueke A; Harmsen WS; Donato LJ
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2962-2970.e6. PubMed ID: 32088296
[TBL] [Abstract][Full Text] [Related]
3. Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome.
Vijayvargiya P; Camilleri M; Burton D; Busciglio I; Lueke A; Donato LJ
Aliment Pharmacol Ther; 2019 Mar; 49(6):744-758. PubMed ID: 30740753
[TBL] [Abstract][Full Text] [Related]
4. Editorial: colesevelam effects on faecal bile acids in IBS with diarrhoea.
Walters JR; Appleby RN
Aliment Pharmacol Ther; 2015 Apr; 41(7):696-7. PubMed ID: 25736144
[No Abstract] [Full Text] [Related]
5. Editorial: colesevelam effects on faecal bile acids in IBS with diarrhoea - author's reply.
Camilleri M
Aliment Pharmacol Ther; 2015 Apr; 41(7):697. PubMed ID: 25736145
[No Abstract] [Full Text] [Related]
6. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function.
Odunsi-Shiyanbade ST; Camilleri M; McKinzie S; Burton D; Carlson P; Busciglio IA; Lamsam J; Singh R; Zinsmeister AR
Clin Gastroenterol Hepatol; 2010 Feb; 8(2):159-65. PubMed ID: 19879973
[TBL] [Abstract][Full Text] [Related]
7. Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: a randomized, double-blind, placebo-controlled study.
Beigel F; Teich N; Howaldt S; Lammert F; Maul J; Breiteneicher S; Rust C; Göke B; Brand S; Ochsenkühn T
J Crohns Colitis; 2014 Nov; 8(11):1471-9. PubMed ID: 24953836
[TBL] [Abstract][Full Text] [Related]
8. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.
Camilleri M; Busciglio I; Acosta A; Shin A; Carlson P; Burton D; Ryks M; Rhoten D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
Am J Gastroenterol; 2014 Oct; 109(10):1621-30. PubMed ID: 25070056
[TBL] [Abstract][Full Text] [Related]
9. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.
Wong BS; Camilleri M; Carlson P; McKinzie S; Busciglio I; Bondar O; Dyer RB; Lamsam J; Zinsmeister AR
Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1009-15.e3. PubMed ID: 22610000
[TBL] [Abstract][Full Text] [Related]
10. Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.
Peleman C; Camilleri M; Busciglio I; Burton D; Donato L; Zinsmeister AR
Clin Gastroenterol Hepatol; 2017 May; 15(5):720-727.e1. PubMed ID: 27856362
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial.
Borup C; Vinter-Jensen L; Jørgensen SPG; Wildt S; Graff J; Gregersen T; Zaremba A; Borup Andersen T; Nøjgaard C; Timm HB; Rainteau D; Hansen SH; Rumessen JJ; Munck LK
Lancet Gastroenterol Hepatol; 2023 Apr; 8(4):321-331. PubMed ID: 36758570
[TBL] [Abstract][Full Text] [Related]
12. Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.
Vijayvargiya P; Busciglio I; Burton D; Donato L; Lueke A; Camilleri M
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):522-527. PubMed ID: 28666948
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea.
Wong BS; Camilleri M; Carlson PJ; Odunsi-Shiyanbade S; McKinzie S; Busciglio I; Burton D; Zinsmeister AR
Dig Dis Sci; 2012 May; 57(5):1222-6. PubMed ID: 22271411
[TBL] [Abstract][Full Text] [Related]
14. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea.
Vijayvargiya P; Camilleri M; Carlson P; Lueke A; O'Neill J; Burton D; Busciglio I; Donato L
Aliment Pharmacol Ther; 2017 Sep; 46(6):581-588. PubMed ID: 28691284
[TBL] [Abstract][Full Text] [Related]
15. Faecal bile acids and colonic bile acid membrane receptor correlate with symptom severity of diarrhoea-predominant irritable bowel syndrome: A pilot study.
Wei W; Wang H; Zhang Y; Zhang Y; Niu B; Chen S; Zhang W; Yao S
Dig Liver Dis; 2021 Sep; 53(9):1120-1127. PubMed ID: 34053874
[TBL] [Abstract][Full Text] [Related]
16. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
Shin A; Camilleri M; Vijayvargiya P; Busciglio I; Burton D; Ryks M; Rhoten D; Lueke A; Saenger A; Girtman A; Zinsmeister AR
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1270-1275.e1. PubMed ID: 23639599
[TBL] [Abstract][Full Text] [Related]
17. Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism.
Brufau G; Stellaard F; Prado K; Bloks VW; Jonkers E; Boverhof R; Kuipers F; Murphy EJ
Hepatology; 2010 Oct; 52(4):1455-64. PubMed ID: 20725912
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire.
Wedlake L; Thomas K; Lalji A; Anagnostopoulos C; Andreyev HJ
Clin Ther; 2009 Nov; 31(11):2549-58. PubMed ID: 20109999
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.
Camilleri M; Shin A; Busciglio I; Carlson P; Acosta A; Bharucha AE; Burton D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(5):G508-16. PubMed ID: 25012842
[TBL] [Abstract][Full Text] [Related]
20. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM
Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
